HSBC has agreed to sell 6.7 billion euros ($7.81 billion) worth of French home loans to British insurer Rothesay and ...

CoreWeave (CRWV) received a Reduce rating and a meager $32 price target by HSBC Global Research due to relatively low returns ...

A U.S. appeals court on Thursday voided the 2017 fraud conviction of a former HSBC executive who spent two years in prison ...

Michael Roberts, the CEO of HSBC Bank plc and CEO of Corporate and Institutional Banking, discusses how clients are ...

HSBC Securities analysts shared their regional ideas and preferences for the second quarter. Among the groups they are ...

Global equities show tactical upside potential with strong Q2 earnings, a weaker dollar, and the impact of the OBBBA Act.

HSBC Holdings Plc faces a rebellion from some of its green clients angered by what they characterize as the London-based bank ...

Relentless dollar-selling is starting to look like a bubble — and, like all bubbles, it will eventually pop, according to ...

After an 8% plunge, HSBC warns investors may be betting too hard against the greenback. Here's what could reverse it.

HSBC analysts found that the potential market for driverless taxis was "widely overestimated" and warned they could take ...

HSBC Holdings PLC closed 2.86% short of its 52-week high of £9.50, which the company reached on March 3rd.

Amgen Inc. (NASDAQ:AMGN) is one of the high-margin pharma stocks to buy now. HSBC has lowered its price target on Amgen Inc.